Racial and Ethnic Disparities in Synchronous and Metachronous Bilateral Breast Cancer

Overview

Journal J Racial Ethn Health Disparities

Specialties Public Health
Social Sciences

Date 2022 Apr 7

PMID 35386052

Authors

D Brock Hewitt

Yaming Li

Oindrila Bhattacharyya

James L Fisher

Daniel Stover

Samilia Obeng-Gyasi

Affiliations

Soon will be listed here.

Abstract

Introduction: Significant racial and ethnic disparities exist in breast cancer treatment and survival. However, studies characterizing these disparities among patients developing bilateral breast cancers (BBC) are lacking. The purpose of this study is to understand the association between race and ethnicity, sociodemographic factors, clinical variables, treatment, and mortality in patients with BBC--synchronous bilateral breast cancer (sBBC) or metachronous bilateral breast cancer (mBBC).

Methods: Patients diagnosed with mBBC or sBBC in the Surveillance, Epidemiology, and End Results program between 2010 and 2016 were examined. sBBC was defined as contralateral breast cancer <1 year after the initial cancer diagnosis, and mBBC was contralateral cancer ≥1 year. Univariable analysis examined sociodemographic, clinical, and treatment variables. Kaplan-Meier curves and Cox regression models evaluated disease-specific mortality.

Results: Of the 11,493 patients that met inclusion criteria, 9575 (83.3%) had sBBC, and 1918 (16.7%) had mBBC. There were significant racial and ethnic differences in stage, tumor subtype, surgical management, and chemotherapy within sBBC and mBBC groups. On adjusted multivariate analysis of all BBC patients, Black race (HR 1.42; 95%CI 1.11-1.80; p<0.005; Ref White) was associated with a higher disease-specific mortality. Conversely, patients with mBBC had a 25% relative risk reduction in disease-specific mortality (HR 0.75; 95%CI 0.61-0.92; p<0.01) compared to sBBC. Subset analysis suggested Black Race modified the effect of sBBC on mortality (p<0.0001).

Conclusions: Among patients with BBC, there are racial and ethnic disparities in clinical characteristics, treatment, and mortality. Future studies should focus on strategies to reduce these disparities.

References

Foy K, Fisher J, Lustberg M, Gray D, DeGraffinreid C, Paskett E . Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women. NPJ Breast Cancer. 2018; 4:7. PMC: 5861087. DOI: 10.1038/s41523-018-0059-5. View

Howlader N, Ries L, Mariotto A, Reichman M, Ruhl J, Cronin K . Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010; 102(20):1584-98. PMC: 2957430. DOI: 10.1093/jnci/djq366. View

Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami H . Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol. 2007; 25(27):4210-6. DOI: 10.1200/JCO.2006.10.5056. View

Hamad A, Li Y, Tsung A, Oppong B, Eskander M, Bhattacharyya O . Hispanic Ethnicity and Breast Cancer: Disaggregating Surgical Management and Mortality by Race. J Racial Ethn Health Disparities. 2021; 9(4):1568-1576. PMC: 8752637. DOI: 10.1007/s40615-021-01096-3. View

Miller J, Smith J, Ryerson A, Tucker T, Allemani C . Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study. Cancer. 2017; 123 Suppl 24:5100-5118. PMC: 5826549. DOI: 10.1002/cncr.30988. View

Kittles R, Weiss K . Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet. 2003; 4:33-67. DOI: 10.1146/annurev.genom.4.070802.110356. View

Hance K, Anderson W, Devesa S, Young H, Levine P . Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005; 97(13):966-75. PMC: 2844937. DOI: 10.1093/jnci/dji172. View

Ozturk A, Alco G, Sarsenov D, Ilgun S, Ordu C, Koksal U . Synchronous and metachronous bilateral breast cancer: A long-term experience. J BUON. 2019; 23(6):1591-1600. View

Jackson D, Li Y, Eskander M, Tsung A, Oppong B, Bhattacharyya O . Racial disparities in low-value surgical care and time to surgery in high-volume hospitals. J Surg Oncol. 2021; 123(2):676-686. DOI: 10.1002/jso.26320. View

10.

Knight J, Bernstein L, Largent J, Capanu M, Begg C, Mellemkjaer L . Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009; 169(8):962-8. PMC: 2727227. DOI: 10.1093/aje/kwn422. View

11.

Megaro G, Rossi L, Ceddia S, Sinjari M, Mannino A, Gozzi E . Synchronous and Metachronous Metastatic Breast Cancer, with Different Histology and Opposite Immunophenotype, Treated with Combination of Chemotherapy, Anti-Her2, and Endocrine Therapy: A Case Report. Case Rep Oncol. 2020; 13(2):544-549. PMC: 7275194. DOI: 10.1159/000507433. View

12.

Yu J, Gross C, Wilson L, Smith B . NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009; 23(3):288-95. View

13.

Chen Y, Thompson W, Semenciw R, Mao Y . Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8(10):855-61. View

14.

Yedjou C, Tchounwou P, Payton M, Miele L, Fonseca D, Lowe L . Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States. Int J Environ Res Public Health. 2017; 14(5). PMC: 5451937. DOI: 10.3390/ijerph14050486. View

15.

Schneider B, Shen F, Jiang G, ONeill A, Radovich M, Li L . Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103. JCO Precis Oncol. 2018; 2017. PMC: 5765553. DOI: 10.1200/PO.17.00059. View

16.

Guidi J, Lucente M, Sonino N, Fava G . Allostatic Load and Its Impact on Health: A Systematic Review. Psychother Psychosom. 2020; 90(1):11-27. DOI: 10.1159/000510696. View

17.

Xiong Z, Yang L, Deng G, Huang X, Li X, Xie X . Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data. J Clin Med. 2018; 7(6). PMC: 6025574. DOI: 10.3390/jcm7060133. View

18.

Begg C, Ostrovnaya I, Geyer F, Papanastasiou A, Ng C, Sakr R . Contralateral breast cancers: Independent cancers or metastases?. Int J Cancer. 2017; 142(2):347-356. PMC: 5749409. DOI: 10.1002/ijc.31051. View

19.

Giannakeas V, Lim D, Narod S . The risk of contralateral breast cancer: a SEER-based analysis. Br J Cancer. 2021; 125(4):601-610. PMC: 8368197. DOI: 10.1038/s41416-021-01417-7. View

20.

Ambrosone C, Young A, Sucheston L, Wang D, Yan L, Liu S . Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget. 2013; 5(1):237-48. PMC: 3960204. DOI: 10.18632/oncotarget.1599. View